Nifty

:

11604.10

Sensex

:

39058.83

15.75 (0.14%)
94.99 (0.24%)

Login

Nifty
Sensex

:
:

11604.10
39058.83

15.75 (0.14%)
94.99 (0.24%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

57/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

24.05

23-Oct-2019

Open
High
Low
Previous Close

24.00
25.05
23.35
24.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4555
1.10
32.70
20.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

63.14
7.63
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

28.39
1.04%
0.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.80
3.84
5.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.07
1.36
10.11

PAT CAGR (%)

10 Years
5 Years
3 Years

-2.44
43.90
-15.25

P:E (Median)

8 Years
5 Years
3 Years

14.29
24.62
8.03

P:BV (Average)

8 Years
5 Years
3 Years

0.73
0.93
0.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

276.23
438.67
735.62

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 45.23 42.40 6.67% 38.40 32.67 17.54% 41.89 38.06 10.06% 44.13 28.91 52.65%
Expenses 43.00 41.16 4.47% 34.99 33.91 3.18% 39.69 40.13 -1.10% 41.65 32.81 26.94%
EBITDA 2.24 1.25 79.20% 3.41 -1.23 - 2.20 -2.07 - 2.48 -3.91 -
EBIDTM 4.95% 2.94% 8.88% -3.78% 5.25% -5.46% 5.61% -13.51%
Other Income 0.67 0.09 644.44% 0.88 0.13 576.92% 0.28 0.03 833.33% 0.18 0.17 5.88%
Interest 0.12 0.17 -29.41% 0.27 0.05 440.00% 0.10 0.23 -56.52% 0.20 0.19 5.26%
Depreciation 0.29 0.25 16.00% 0.28 0.02 1,300.00% 0.23 0.02 1,050.00% 0.25 0.02 1,150.00%
PBT 2.50 0.91 174.73% 3.74 -1.17 - 2.14 -2.29 - 2.21 -3.95 -
Tax 0.50 0.18 177.78% 0.76 0.06 1,166.67% 0.40 -0.05 - 0.44 -0.09 -
PAT 2.00 0.73 173.97% 2.98 -1.23 - 1.74 -2.25 - 1.77 -3.85 -
PATM 4.43% 1.71% 7.75% -3.76% 4.16% -5.90% 4.01% -13.33%
EPS 0.76 0.28 171.43% 1.14 -0.47 - 0.67 -0.86 - 0.68 -1.47 -

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 169.65 166.83 126.53 143.87 143.49 138.15 143.85 166.46 176.51 160.96 139.59 Net Sales Growth 19.44% 31.85% -12.05% 0.26% 3.87% -3.96% -13.58% -5.69% 9.66% 15.31% Cost Of Goods Sold 69.98 72.85 61.11 58.95 59.13 68.68 64.71 86.16 84.54 83.00 75.50 Gross Profit 99.67 93.98 65.42 84.92 84.36 69.47 79.14 80.30 91.97 77.95 64.09 GP Margin 58.75% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% 48.24% 52.10% 48.43% 45.91% Total Expenditure 159.33 157.49 137.64 138.10 131.68 129.42 133.17 156.41 159.90 146.42 123.88 Power & Fuel Cost - 1.41 1.00 2.12 2.26 1.77 2.23 2.55 2.52 2.05 1.44 % Of Sales - 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% 1.53% 1.43% 1.27% 1.03% Employee Cost - 46.61 41.88 40.95 37.84 32.11 37.83 37.25 36.51 32.22 22.53 % Of Sales - 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% 22.38% 20.68% 20.02% 16.14% Manufacturing Exp. - 0.73 0.96 1.34 1.70 1.01 1.57 2.01 1.04 1.51 0.53 % Of Sales - 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% 1.21% 0.59% 0.94% 0.38% General & Admin Exp. - 19.03 16.31 16.44 13.61 9.64 8.55 8.87 8.87 7.52 9.47 % Of Sales - 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% 5.33% 5.03% 4.67% 6.78% Selling & Distn. Exp. - 13.20 11.25 13.74 12.96 11.53 14.36 15.45 20.28 14.98 9.97 % Of Sales - 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% 9.28% 11.49% 9.31% 7.14% Miscellaneous Exp. - 3.66 5.14 4.56 4.19 4.67 3.92 4.11 6.14 5.13 9.97 % Of Sales - 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% 2.47% 3.48% 3.19% 3.17% EBITDA 10.33 9.34 -11.11 5.77 11.81 8.73 10.68 10.05 16.61 14.54 15.71 EBITDA Margin 6.09% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% 6.04% 9.41% 9.03% 11.25% Other Income 2.01 1.43 0.46 0.47 0.66 0.11 0.06 0.32 0.37 0.26 0.36 Interest 0.69 0.75 0.66 2.64 5.30 4.46 5.38 5.13 4.36 3.32 3.50 Depreciation 1.05 1.02 0.32 1.99 3.09 2.71 2.83 2.71 2.54 2.20 2.08 PBT 10.59 9.00 -11.63 1.60 4.08 1.67 2.53 2.54 10.09 9.27 10.50 Tax 2.10 1.79 -0.08 2.53 0.82 0.50 0.41 0.70 2.63 2.09 1.26 Tax Rate 19.83% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% 27.56% 26.07% 22.55% 12.00% PAT 8.49 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 7.18 9.24 PAT before Minority Interest 8.49 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 7.18 9.24 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.00% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% 1.10% 4.23% 4.46% 6.62% PAT Growth 228.64% - - 264.92% 177.78% -44.81% 15.85% -75.47% 3.90% -22.29% Unadjusted EPS 3.25 2.75 -4.41 4.53 1.24 0.45 0.81 0.70 2.85 2.74 3.53

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 104.47 98.05 109.91 98.36 95.43 98.59 98.37 98.47 92.91 87.57 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 91.37 84.95 96.81 85.27 82.33 85.49 85.27 85.37 79.81 74.47 Non-Current Liabilities 3.12 3.19 3.26 3.61 3.60 4.08 4.50 4.25 3.63 23.37 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.71 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.32 0.27 0.26 4.57 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 28.19 28.58 29.44 57.31 55.19 53.58 50.13 53.38 40.17 12.29 Trade Payables 11.86 9.09 8.98 9.73 7.87 5.08 6.51 8.14 4.61 5.67 Other Current Liabilities 5.60 6.10 7.12 6.61 6.24 5.48 3.99 4.79 3.42 4.63 Short Term Borrowings 3.79 8.30 7.93 38.49 39.31 35.96 33.09 34.62 28.33 0.00 Short Term Provisions 6.95 5.09 5.41 2.48 1.77 7.06 6.55 5.83 3.81 2.00 Total Liabilities 135.78 129.82 142.61 159.28 154.22 156.25 153.00 156.10 136.71 123.23 Net Block 21.64 21.32 21.59 51.61 51.96 56.41 58.35 59.15 57.68 53.19 Gross Block 55.00 53.66 52.88 90.35 87.61 87.01 85.75 83.44 79.06 72.05 Accumulated Depreciation 33.36 32.34 31.28 38.74 35.65 30.60 27.41 24.29 21.38 18.86 Non Current Assets 38.23 35.20 32.50 58.32 58.43 64.94 66.46 65.17 60.87 53.19 Capital Work in Progress 3.95 3.04 0.00 0.00 0.00 2.35 2.33 0.93 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.63 10.84 10.90 6.71 6.47 6.19 5.78 5.09 3.19 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 97.56 94.61 110.11 100.96 95.79 91.31 86.54 90.93 75.85 70.05 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 32.69 51.43 47.62 39.84 33.06 30.59 30.07 35.22 22.55 22.43 Sundry Debtors 20.75 25.15 39.41 41.69 44.89 45.22 42.20 42.31 42.98 37.88 Cash & Bank 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 5.63 Other Current Assets 5.58 0.24 0.23 0.00 2.83 2.90 3.93 3.53 2.98 4.10 Short Term Loans & Adv. 4.64 3.27 2.80 3.90 2.83 2.90 3.93 3.53 2.98 4.10 Net Current Assets 69.37 66.03 80.68 43.65 40.60 37.73 36.41 37.55 35.67 57.76 Total Assets 135.79 129.81 142.61 159.28 154.22 156.25 153.00 156.10 136.72 123.24

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 30.90 -1.58 -3.24 9.04 4.30 7.52 12.05 7.08 4.97 0.86 PBT 9.00 -11.63 14.40 4.08 1.67 2.53 2.54 10.09 9.27 10.50 Adjustment 0.33 1.26 -8.63 7.73 7.05 8.15 7.52 6.52 5.26 5.37 Changes in Working Capital 19.71 8.79 -6.13 -1.96 -4.09 -2.65 2.50 -7.51 -7.47 -8.73 Cash after chg. in Working capital 29.05 -1.58 -0.36 9.85 4.63 8.02 12.56 9.10 7.06 7.14 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.50 Tax Paid 1.85 0.00 -2.88 -0.82 -0.33 -0.51 -0.51 -2.02 -2.09 -1.26 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.53 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.83 -3.37 41.29 -2.09 -0.46 -1.21 -3.39 -4.94 -6.75 -2.10 Net Fixed Assets -2.25 -3.82 37.47 -2.74 1.75 -1.28 -3.71 -5.31 -7.01 -2.10 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 1.42 0.45 3.82 0.65 -2.21 0.07 0.32 0.37 0.26 0.00 Cash from Financing Activity -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 -8.19 0.41 3.47 1.28 Net Cash Inflow / Outflow 24.02 -5.55 4.53 0.52 2.41 2.26 0.46 2.56 1.69 0.03 Opening Cash & Equivalents 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 5.63 0.18 Closing Cash & Equivalent 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 0.21

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 36.89 34.43 38.96 34.55 33.43 32.86 32.63 32.52 30.25 28.09 ROA 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% 1.19% 5.09% 5.52% 7.51% ROE 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% 2.15% 9.07% 9.39% 13.25% ROCE 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% 6.42% 12.68% 12.48% 14.91% Fixed Asset Turnover 3.07 2.38 2.03 1.62 1.59 1.68 2.01 2.22 2.19 2.44 Receivable days 50.22 93.07 102.03 109.58 118.23 109.72 90.52 86.16 89.25 95.51 Inventory Days 92.03 142.78 110.02 92.27 83.52 76.13 69.93 58.36 49.65 56.63 Payable days 31.91 27.07 22.17 21.36 15.26 9.95 12.35 10.51 12.93 14.34 Cash Conversion Cycle 110.33 208.78 189.88 180.49 186.49 175.90 148.10 134.00 125.97 137.80 Total Debt/Equity 0.04 0.09 0.08 0.43 0.45 0.42 0.39 0.41 0.36 0.28 Interest Cover 13.08 -16.69 6.44 1.77 1.37 1.47 1.49 3.32 3.79 4.00

Top Investors:

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
13th Aug 2019, 16:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback